Donate
Home
About the LRG
Patient Support
LRG Research
LRG Library
Medical Professionals
The Life Raft Group - Ensuring that no one has to face GIST alone The Life Raft Group - Ensuring that no one has to face GIST alone
My name is Katie. I love to spend time with my son, Connor and husband, Marc.
My name is Katie. I love to spend time with my son, Connor and husband, Marc.
The Life Raft Group - Ensuring that no one has to face GIST alone
About GIST
Frequent Topics
Accessing Treatment
Coping with Cancer

Life Fest 2010 Awards

Click here to view the Life Fest 2010 honorees

Humanitarian of the Decade Awards
   
Dr. Daniel Vasella
Daniel Vasella, M.D., is Chairman of the Board and former CEO of Novartis AG. He was appointed Chairman in April 1999, having served as CEO and Head of the Group Executive Committee since the merger that created Novartis in 1996. As the first CEO of Novartis, Dr. Vasella had a leading role in the merger of Sandoz and Ciba-Geigy. Under Dr. Vasella, Novartis has strategically focused its business on health care with Pharmaceuticals as its core. During his tenure as Chairman and CEO, Dr. Vasella has enhanced the company’s corporate governance policies in line with best practices and listed Novartis on the New York Stock Exchange. He has also strengthened the research capacity of Novartis in leading technologies by creating the Novartis Institute for BioMedical Research and moving the company’s research headquarters to Cambridge, Mass., to be closer to top scientific talent as well as patient and hospital networks. He also established The Genomics Institute of the Novartis Research Foundation, which is focused on developing therapeutics from the data generated from the mapping of the human genome.

Dr. Vasella has implemented strong pioneering initiatives to ensure access to medicines, which include the founding of the Novartis Institute for Tropical Diseases for research on neglected diseases of the developing world, the International Patient Assistance Program for the breakthrough GIST drug Gleevec/Glivec, an agreement to supply the novel malaria treatment Coartem® at cost to the World Health Organization and a pledge to donate the drug therapy needed to eradicate leprosy worldwide. Furthermore, under Dr. Vasella’s leadership, Novartis subscribed to the UN Global Compact initiative.

A 2004 readership survey of the Financial Times selected Dr. Vasella as the most influential European businessman of the past quarter century. In 2003, Dr. Vasella was awarded The CancerCare Human Services Award and also the Harvard Business School’s Alumni Achievement Award. Dr. Vasella was awarded an honorary doctorate by the Faculty of Medicine at the University of Basel in 2002, and he was given the Appeal of Conscience Award in February 2000. In 1998, he received the AJ Congress Humanitarian Award. He has been honored with the Ordem Nacional do Cruzeiro do Sul (Brazil) and holds the rank of Chevalier in the Ordre National de la Légion d’Honneur (France).

Before the Novartis merger, Dr. Vasella was CEO of Sandoz Pharma Ltd. and a member of the Sandoz Group Executive Committee. From 1988 to 1992, he was with Sandoz Pharmaceuticals Corporation in the US, prior to which he held a number of medical positions in Switzerland. Dr. Vasella is a member of the Board of Directors of PepsiCo, Inc., United States. In addition, he is a member of the Chairman’s Council of DaimlerChrysler AG, Germany, and a member of the Board of Dean’s Advisors at the Harvard Business School. He is also President of the International Federation of Pharmaceutical Manufacturers Associations, a member of the International Board of Governors of the Peres Center for Peace in Israel and a member of the International Business Leaders Advisory Council for the Mayor of Shanghai.

Dr. Vasella is a two-time PharmaVOICE 100 winner, which is a life sciences magazine that annually profiles the men and women in the life-sciences industry who are truly making a difference. He is married and has three children. Dr. Vasella was honored by the Life Raft Group as the “Humanitarian of the Year” at Life Fest 2002 in Cambridge, Mass.
 
Cool Doctor of the Year
Dr. George Demetri

Dr. George D. Demetri is Associate Professor of Medicine at Harvard Medical School and Director of the Center for Sarcoma and Bone Oncology in the Department of Medical Oncology at the Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts. Dr. Demetri received his undergraduate degree in Biochemistry from Harvard College and medical degree from Stanford University School of Medicine in 1983, then went on to Internal Medicine residency and chief residency at the University of Washington Hospitals in Seattle. He then completed a fellowship in Medical Oncology at the Dana-Farber Cancer Institute and Harvard Medical School, where he has served as an Attending Physician since 1989. He is also an affiliate investigator with the Ludwig Institute for Cancer Research.


Dr. Demetri's research and clinical interests have focused on the translation of scientific discoveries into targeted drugs for the management of sarcomas as a model for solid tumor research and development. This work has led to the development of the oral drug Gleevec as an effective treatment for the gastrointestinal sarcoma known as GIST, and is continuing with the research leading to the new multi-targeted agent SU11248 for GIST resistant to Gleevec.
A fellow of the American College of Physicians, Dr. Demetri is a member of many professional societies and editorial boards of scientific journals. He is a member of the Board of Directors of the Connective Tissue Oncology Society, the chair of the Medical Advisory Board of the Sarcoma Alliance, and a member of the Medical Advisory Board of the Sarcoma Foundation of America. He has been instrumental in raising awareness of issues relating to sarcoma research and care by his activities on the Internet, and he founded a non-profit educational site for sarcoma patients and their families.
 
GIST Hall of Fame
To view pictures and information about the GIST Hall of Fame honorees, click here.

Dr. J. Aidan Carney
Dr. Christopher Corless
Dr. George Demetri
Dr. Brian Druker
Dr. Jonathan Fletcher
Mr. Gilles Frydman & ACOR
For Gleevec:
Dr. Elisabeth Buchdunger
Dr. Renaud Capdeville
Dr. Laurie Letvak
Dr. Nicholas Lydon
Dr. Alex Matter
Dr. Jürg Zimmermann
Dr. Michael Heinrich
Dr. Seiichi Hirota
Mr. Jeffrey Kindler & Pfizer
The National Institutes of Health Clinic

The Gleevec Trial Doctors:
Dr. George Demetri
Dr. Margaret Von Mehren
Dr. Charles Blanke
Dr. Heikki Joensuu

For Sutent:
Dr. Zuleima Aguilar
Ms. Elizabeth Barrett
Mr. Carlo Bello
Dr. James Christensen
Dr. Darrel Cohen
Mr. Stephen Evans-Freke
Dr. Joseph Schlessinger
Dr. Axel Ullrich

Dr. Daniel Vasella & Novartis
Dr. James Watson
The GIST Patient:
Patient Advocacy Groups

   
 
 
GIST Clinician of the Year
 
Dr. Jonathan Trent

Jonathan C. Trent is an Associate Professor of Medicine in the Department of Sarcoma Medical Oncology who specializes in the laboratory, translational, and clinical research of gastrointestinal stromal tumor. Dr. Trent’s clinical care is devoted primarily to GIST patients. Dr. Trent earned his undergraduate degree in chemistry at Southeastern Oklahoma State University and his MD and PhD in cancer biology from The University of Texas Health Science Center. He has completed an internship and residency in internal medicine at The University of Texas Health Science Center, and a fellowship in medical oncology at The M. D. Anderson Cancer Center.

 
 
Volunteer of the Year
Vicky Ossio

Virginia (Vicky) was born and raised in Bolivia, where she attended University in La Paz, later graduating from the University of Arkansas with a major in Sociology.

A mother of two, Vicky started her volunteer work at age 12 as a girl scout.  At age 17, she helped illiterate people to read and write as part of a program of the Catholic Church. She went on to join a volunteer organization, Partners of the Americas, where she was trained in gardening to help communities in need, and also helped with an educational reform program in rural areas of Bolivia. 

For the last seven years, Vicky and her husband Marcelo Levy have owned an animal refuge center in a small paradise two hours away from La Paz, where they care for more than 250 animals.

Vicky has been a member of the LRG since January 2006, when her daughter, Carolina was diagnosed with GIST. Since then, she has assisted the Life Raft Group with various projects including the translation of educational materials, coordination of international meetings and most recently, helping to launch the Latin American GIST Coalition.

 
 

 

 


This website is accredited by Health On the Net Foundation. Click to verify. We subscribe to the HONcode principles. Verify Here
This website is dedicated in perpetuity to the memory of Mary S. Golnik
JT IMAGES, Inc. - Website designer
© Copyright 2009 Life Raft Group. All rights Reserved.
Last Modified - November 22, 2011 3:40pm
View the Life Raft Group Policies and Disclaimer